Proxyfan

Last updated
Proxyfan
Proxyfan.svg
Names
Preferred IUPAC name
4-[3-(Benzyloxy)propyl]-1H-imidazole
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
PubChem CID
UNII
  • InChI=1S/C13H16N2O/c1-2-5-12(6-3-1)10-16-8-4-7-13-9-14-11-15-13/h1-3,5-6,9,11H,4,7-8,10H2,(H,14,15)
    Key: WNWALBVQAAIULR-UHFFFAOYSA-N
  • C1=CC=C(C=C1)COCCCC2=CN=CN2
Properties
C13H16N2O
Molar mass 216.284 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Proxyfan is a histamine H3 receptor ligand which is a "protean agonist", producing different effects ranging from full agonist, to antagonist, to inverse agonist in different tissues, depending on the level of constitutive activity of the histamine H3 receptor. This gives it a complex activity profile in vivo which has proven useful for scientific research. [1] [2] [3] [4] [5] [6] [7]

References

  1. ↑ Morisset, S.; Rouleau, A.; Ligneau, X.; Gbahou, F.; Tardivel-Lacombe, J.; Stark, H.; Schunack, W.; Ganellin, C. R.; Schwartz, J. C.; Arrang, J. M. (2000). "High constitutive activity of native H3 receptors regulates histamine neurons in brain". Nature. 408 (6814): 860–864. doi:10.1038/35048583. PMID   11130725.
  2. ↑ Fox, G. B.; Pan, J. B.; Esbenshade, T. A.; Bitner, R. S.; Nikkel, A. L.; Miller, T.; Kang, C. H.; Bennani, Y. L.; Black, L. A.; Faghih, R.; Hancock, A. A.; Decker, M. W. (2002). "Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model". Pharmacology, Biochemistry, and Behavior. 72 (3): 741–750. doi:10.1016/s0091-3057(02)00745-1. PMID   12175472.
  3. ↑ Gbahou, F.; Rouleau, A.; Morisset, S.; Parmentier, R.; Crochet, S.; Lin, J. S.; Ligneau, X.; Tardivel-Lacombe, J.; Stark, H.; Schunack, W.; Ganellin, C. R.; Schwartz, J. C.; Arrang, J. M. (2003). "Protean agonism at histamine H3 receptors in vitro and in vivo". Proceedings of the National Academy of Sciences of the United States of America. 100 (19): 11086–11091. doi: 10.1073/pnas.1932276100 . PMC   196931 . PMID   12960366.
  4. ↑ Baldi, E.; Bucherelli, C.; Schunack, W.; Cenni, G.; Blandina, P.; Passani, M. B. (2005). "The H3 receptor protean agonist proxyfan enhances the expression of fear memory in the rat". Neuropharmacology. 48 (2): 246–251. doi:10.1016/j.neuropharm.2004.09.009. hdl: 2158/220558 . PMID   15695163.
  5. ↑ Krueger, Kathleen M.; Witte, David G.; Ireland-Denny, Lynne; Miller, Thomas R.; Baranowski, John L.; Buckner, Steve; Milicic, Ivan; Esbenshade, Timothy A.; Hancock, Arthur A. (2005). "G Protein-Dependent Pharmacology of Histamine H3 Receptor Ligands: Evidence for Heterogeneous Active State Receptor Conformations". Journal of Pharmacology and Experimental Therapeutics. 314 (1): 271–281. doi:10.1124/jpet.104.078865. PMID   15821027.
  6. ↑ Arrang, J. M.; Morisset, S.; Gbahou, F. (2007). "Constitutive activity of the histamine H3 receptor". Trends in Pharmacological Sciences. 28 (7): 350–357. doi:10.1016/j.tips.2007.05.002. PMID   17573125.
  7. ↑ Baker, Jillian G. (2008). "Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cells". BMC Pharmacology. 8 9. doi: 10.1186/1471-2210-8-9 . PMC   2430196 . PMID   18538007.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.